CaƱete, Al-jadid S.
HRN: 20-50-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/13/2022
10/19/2022
IVT
80mg
Q8hrs
Amoebiasis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes